In Vitro Fertilization Market Research Report- Forecast To 2030

In Vitro Fertilization Market Share, Growth And Trends Analysis By Type (Intrauterine Insemination, Intracytoplasmic Sperm Injection, Ivf Using Donor Eggs), By Devices (Imaging Systems, Sperm Separation System, Ovum Aspiration Pump, Micromanipulator, Cryosystem) By Reagents (Embryo Culture Media, Cryopreservation Media, Sperm Processing Media, Ovum Processing Media), By End Users (Clinical Research Institutes, Fertility Clinics, Hospitals) - Forecast to 2030

ID: MRFR/LS/1682-CR | October 2018 | Region: Global | 80 Pages         

In Vitro Fertilization Market Speak to Analyst Request a Free Sample

In Vitro Fertilization Market

In Vitro Fertilization Market to hit USD 34.9 Billion by 2030 at a CAGR 5.7% during the forecast period 2022-2030

Segmentation
By Type Intrauterine Insemination Intracytoplasmic Sperm Injection Ivf Using Donor Eggs
By Devices Imaging Systems Sperm Separation System Ovum Aspiration Pump Micromanipulator Cryosystem
By Reagents Embryo Culture Media Cryopreservation Media Sperm Processing Media Ovum Processing Media
By End Users Clinical Research Institutes Fertility Clinics Hospitals
Key Players
Companies Profiled   Cooper Surgical Fertility   Cook Medical   Oxford Gene Technology   Merck KGaA   INVO Bioscience   Thermo Fisher Scientific   Genea Limited   Irvine Scientific   Vitrolife GENEA BIOMEDIX
Drivers
Market Driving Forces   Robust Regulatory Frameworks   High Average Conception Age
Request a Free Sample

In Vitro Fertilization Market Overview


In Vitro Fertilization Market size was valued USD 21.4 Billion in 2021 and is expected to reach USD 34.9 Billion by 2030 at CAGR of 5.7% during the forecast period 2022-2030. In vitro fertilization (IVF) is an assisted reproductive technology that includes the collection of eggs from a woman's ovaries and fertilizing with sperm outside the body in a laboratory. In the few years, the number of women delaying pregnancies past the age of 35 has rapidly grown. Infertility is caused due to delay in pregnancy. In many conditions, delayed pregnancies lead to pregnancy-related problems and the risk of infertility. The increased awareness has enhanced the vitro fertilization (IVF) procedures. IVF success rates have propelled, and problems caused by delayed pregnancy led to a higher demand for in vitro fertilization techniques worldwide. Furthermore, the increased number of delayed pregnancies contributes to the use of IVF procedures. However, the market's growth will be limited throughout the forecast period due to the challenges with IVF and the socio-ethical issues.


The cost of IVF in Asia-Pacific is lesser, especially in India, s. The medical tourism in the region for IVF is also assessed to supplement the growth of the Asia-Pacific in vitro fertilization IVF market in the region. Due to lenient legal measures and regulatory necessities, India's fertility centers can deliver more patient-oriented therapies when equated with the advanced areas, directing the development of the IVF disposables market in the region.


COVID-19 Analysis of In Vitro Fertilization Market


The financial consequences of folding job losses and the housing market are estimated to develop the fertility clinic industry substantially. The shuttering of IVF clinics is also estimated to amplify waiting lists for couples trying to conceive this year. The surge in households' expenditure is expected to create severe restrictions on the development of the in vitro fertilization market share in the approaching period. Moreover, as fertility-related issues are not critical to an individual's health and well-being, especially in the current pandemic's scope, they are predicted to contribute to decelerated development in the market growth.


In Vitro Fertilization Market Dynamics


Drivers


Robust Regulatory Frameworks


The existence of suitable regulatory frameworks has aided in the development of assisted reproduction technologies such as embryo culture media market are likely to gain quick acceptance in advanced economies. At the same time, their penetration remains relatively slower in developing countries.


High Average Conception Age


The average age of first-time mothers has multiplied radically in the global in vitro fertilization market. This inclination is estimated to improved contraceptive techniques and the mounting number of women choosing to delay the starting of a family.


Opportunities


Progressive Technology Availability


The intensification of infertility cases is contributing to the advancement of advanced technologies such as lensless imaging of the sperms, which is anticipated to usher in a new phase of growth in the market share in the coming years.


Surge in Fertility Medical Tourism


The low cost for superior healthcare amenities provided by doctors and surgeons trained in the leading institutes in the US and Europe in developing economies such as that of the Asia Pacific region promotes the in vitro fertilization trends. In addition to reduced treatment costs, combined with quality treatments and noninterventionist laws concerning the IVF treatment, it is also motivating fertility tourism in evolving countries such as India and Thailand.


Restraints 


High Cost Of Treatment


The cost of IVF treatment differs due to the absence of reimbursement policies, which may hinder its global progress. Consequently, the astronomical price of assisted reproductive techniques and the absence of insurance coverage for the treatment are restraining this in vitro fertilization market growth.


In Vitro Fertilization Market Segment Overview


By Type


The intrauterine insemination (IUI) segment is anticipated to keep on as a highly appealing segment over the next few years. In 2017, the segment accounted for nearly one-third share of the global IVF device market. During the forecast period, the segment is expected to witness a double-digit CAGR.


By Devices


The segments by device such as ovum aspiration pump, imaging systems, micromanipulator, sperm separation system, and cryosystem are assessed to perform uniformly in the course of the forecast period due to their use in fertilization.


By Reagents


The reagents segments are estimated to develop consistently in the course of the forecast period.


By End Users


The fertility clinics segment currently influences the in vitro fertilization market largest share and is anticipated to hold its top-posting over the forecast period. The hospital segment is also projected to become more lucrative in the upcoming years. Throughout the forecast period, the hospital segment is anticipated to surge at a 12.92% CAGR.


Regional Analysis


Asia Pacific To Be Established A Key Frontrunner In Global In Vitro Fertilization Market By 2030


The cost of IVF in Asia-Pacific is substantially lesser, especially in India, when likened to industrialized regions. The mounting medical tourism in the region for IVF is also assessed also to supplement the growth of the Asia-Pacific in vitro fertilization IVF market in the region. Due to lenient legal measures and regulatory necessities, India's fertility centers can deliver more patient-oriented therapies when equated with the advanced regions, which is directing the development of the IVF disposables market in the region.


North American Region To Capitalize Access To Innovative Technology


Several progressive nations in Europe and the Americas are documenting a lesser birthrate, which is linked to several socioeconomic influences. As a result, technologies such as IVF have become very popular in these countries. Meanwhile, the developing countries in the North American region, such as Mexico, are also catching up with the trend.


In Vitro Fertilization Market Competitive Landscape


The noteworthy companies profiled in the market report are



  • Cooper Surgical Fertility,

  • Cook Medical,

  • Oxford Gene Technology,

  • Merck KGaA,

  • INVO Bioscience,

  • Thermo Fisher Scientific,

  • Genea Limited,

  • Irvine Scientific,

  • Vitrolife

  • GENEA BIOMEDIX


The government in Quebec plans to comprise in vitro fertilization to their government-funded health services. The procedure currently costs at least USD 6,000, not counting the expense of the hormones a patient must take. The subsidized treatment will be accessible to heterosexual couples, lesbian couples, as well as to single women.  This development is estimated to signify a pathbreaking development in the in vitro fertilization market.


Recent Developments


In May 2022


Future Fertility, a fertility technology company developing AI-enabled and non-invasive solutions to optimize clinical decision-making for fertility specialists, today announced that Christine Prada was named Chief Executive Officer. Her employment with Future Fertility will commence in early May.


In April 2022


MRW Life Sciences, the world's first automated platform to safeguard frozen eggs and embryos central to in vitro fertilization (IVF), earned the first spot on Fast Company's 2022 list of the top innovative biotech companies. TMRW's technology delivered digital identification and traceability of eggs and embryos and process automation, replacing outdated systems and increasing safety and transparency before TMRW introduced its new platform, the standard of care for preserving and managing frozen eggs and embryos dated back to the beginnings of human IVF in the 1970s.


Report Overview


In Vitro Fertilization Market Segmentation Table


By Type



  • Intrauterine Insemination,

  • Intracytoplasmic Sperm Injection,

  • IVF Using Donor Eggs


By Devices



  • Imaging Systems,

  • Sperm Separation System,

  • Ovum Aspiration Pump,

  • Micromanipulator,

  • Cryosystem


By Reagents



  • Embryo Culture Media,

  • Cryopreservation Media,

  • Sperm Processing Media,

  • Ovum Processing Media,


By End-User



  • Fertility Clinics

  • Hospitals

  • Clinical Research Centers


By Region



  • North America

  • Europe

  • Asia Pacific

  • The Middle East & Africa (MEA)

  • Latin America


The MRFR report advances a factual viewpoint for market share on worldwide scale. The report consists of a comprehensive analysis of the growth trends of the global market. The report has thoroughly discussed the key micro and macroeconomic elements influencing the In-Vitro Fertilization (IVF) Industry.



Report Scope:

Report Attribute/Metric Details
  Market Size   USD 34.9 Billion
  CAGR   5.7%
  Base Year   2020
  Forecast Period   2030
  Historical Data   2022
  Forecast Units   USD (Billions)
  Report Coverage   Significant Value Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   By Type, Devices, Reagents and End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Cooper Surgical Fertility, Cook Medical, Oxford Gene Technology, Merck KGaA, INVO Bioscience, Thermo Fisher Scientific, Genea Limited, Irvine Scientific, Vitrolife, GENEA BIOMEDIX
  Key Market Opportunities

  • Progressive Technology Availability
  • Surge in Fertility Medical Tourism
  •   Key Market Drivers

  • Robust Regulatory Frameworks
  • High Average Conception Age


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    The global in-vitro fertilization market can touch USD 34.7 Billion by 2030.

    Thermo Fisher Scientific, Merck KGaA, GENEA BIOMEDIX, Cook Medical, Oxford Gene Technology, Irvine Scientific, Vitrolife, Cooper Surgical Fertility, INVO Bioscience, and Genea Limited are major players of the global in-vitro fertilization market.

    The global in-vitro fertilization market is expected to exhibit a CAGR of 5.7% from 2022 to 2030.

    Europe can dominate the global in-vitro fertilization market due to government funding for research in infertility treatments.

    The MEA region is expected to hold the lowest share of the global in-vitro fertilization market.